SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615774-17-000139
Filing Date
2017-01-17
Accepted
2017-01-17 16:32:55
Documents
2
Period of Report
2017-01-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K s105123_8k.htm 8-K 16222
2 EXHIBIT 10.1 s105123_ex10-1.htm EX-10.1 219956
  Complete submission text file 0001615774-17-000139.txt   237361
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27072 | Film No.: 17531068
SIC: 2836 Biological Products, (No Diagnostic Substances)